Screening data software costs, from the public record

Genedata Screener price and Genedata software license cost from 21 federal awards

Genedata publishes no price for Screener. US federal procurement records are public, so here is what the Army, the EPA and the NIH actually paid for Screener and Analyst, alongside the read-out that decides which compounds reach a plate in the first place.

From $149 a month

21 federal awards to Genedata
One Army series, renewed each September
Screener and Analyst kept apart

The activity call that comes before the plate

of 3 left

Compound, by name or SMILES

Strain panel

S. aureus (MRSA) E. coli K. pneumoniae (CRE) A. baumannii P. aeruginosa E. faecium (VRE)

Read-out

Include closest published analogs

No account needed. 3 screens per session.

What comes back

Rows: One per strain in the panel
Per row: MIC band, S I R call, mechanism
Support: Confidence 1 to 4 and analogs
Typical run: About ten seconds

Sample output Ciprofloxacin Fluoroquinolone

Worked example, replaced when you run

Strain	MIC (µg/mL)	Call	Resistance risk
S. aureus (MRSA)	0.5->32	R Resistant	target mutation, grlA and gyrA Fluoroquinolone resistance is widespread in methicillin resistant lineages.
E. coli	<=0.015-0.06	S Susceptible	efflux, AcrAB-TolC in resistant isolates Potent against wild type; qnr carriage and gyrA changes shift the band sharply.
K. pneumoniae (CRE)	0.5->64	R Resistant	gyrA mutation with plasmid qnr Carbapenemase producing isolates almost always carry quinolone resistance too.
A. baumannii	8->64	R Resistant	efflux, AdeABC Constitutive efflux plus target changes leave little room at achievable exposure.
P. aeruginosa	0.25-2	I Intermediate	efflux, MexAB-OprM Borderline: active on many isolates, lost quickly once efflux is derepressed.
E. faecium (VRE)	4->32	R Resistant	target mutation, parC Enterococci are intrinsically poor fluoroquinolone targets.

Why

Ciprofloxacin is a well characterised fluoroquinolone, so the Gram-negative bands are strongly supported by published activity data. The deciding factor across this panel is not target affinity but exposure: efflux in P. aeruginosa and A. baumannii, and acquired target mutation everywhere resistance is already common. Against a modern ESKAPE panel it reads as a Gram-negative agent with two reliable losses.

Closest published analogs

Levofloxacin Broadly similar Gram-negative bands, better Gram-positive coverage
Delafloxacin Retains activity against many ciprofloxacin resistant staphylococci

Strain	MIC (µg/mL)	Call	Resistance risk	Conf.

Why

Closest published analogs

Want the rest of your series? Batch runs are on the paid tiers. screen left in this session. This session is used up.

Computational prediction from published literature. Research use only, not a lab measurement and not clinical guidance.

The short answer

What Genedata Screener costs, in one paragraph

Genedata does not publish a price for Screener. The US federal award record does. The Army held a Screener subscription at $73,700 a year in 2016 and 2017, renewed it at $77,000 and $85,340, then signed a three year license at $330,240, about $110,080 a year. The EPA paid $38,000 for one concurrent user in 2008. These are government terms, so a company should read them as a floor for a commercial quote, not a forecast.

one concurrent user, 2008: $38,000
a year, Army, 2020 to 2023: $110,080
across all 21 awards: $1.31m

384 well plate 7 hits of 320 compounds

Negative control Positive control Hit

Screener's job starts here: normalize the plate against its controls, fit the curves, call the hits. Which 320 compounds went on the plate was decided earlier.

One subscription, renewed every September

The Army Screener subscription, year by year

Every Army award to Genedata from 2016 on ends on September 14 or 15, and two of them carry the same product code, GDUSS0851FD. That shared anniversary is what makes them one agreement renewed each year rather than a string of separate purchases. The 2018 award names USAMRIID, the Army's infectious disease research institute at Fort Detrick. Multi year awards are shown at their total divided by the years they cover.

2016

$73,700
Two year subscription, $147,400, product code GDUSS0851FD, per year of a two year award
2017

$73,700
Second year of the same award, per year of a two year award
2018

$77,000 Up 4.5%
Same product code, award text names USAMRIID, one year
2019

$85,340 Up 10.8%
License, maintenance and support of Genedata Screener, one year
2020

$110,080 Up 29.0%
Three year Genedata software license, $330,240, per year of a three year award
2021

$110,080
Second year of the same award, per year of a three year award
2022

$110,080
Third year of the same award, per year of a three year award

Two small steps, then a big one

The subscription rose 4.5 percent in 2018 and 10.8 percent in 2019. The 2020 award then came in about 29 percent above the 2019 year, and it changed contracting office and wording, from a named Screener license to a Genedata software license. A jump of that size usually means added modules or users, not an uplift. The record does not list line items, so if your own renewal moves by a quarter, ask for them.

The 2024 award, read carefully

The Defense Health Agency signed a Genedata Screener base year at $133,175 from September 15, 2024, with a term recorded to September 2026. The record does not say whether that figure covers one year or the base year plus an exercised option, so it stays out of the chart. Read as one year it is 21 percent above 2022; read as two it is well below. Either way, the September anniversary held.

The smallest license on record

One concurrent user at the EPA

The only Genedata award that states a seat count is the EPA's first: a Genedata Screener yearly license for one concurrent user at $38,000, June 2008. The agency renewed for two more years. The second year rose 24 percent, which reads like a first year that did not yet include full maintenance, and the third rose 3.0 percent, the size of an ordinary uplift.

These are old figures, and they are the closest public number to what a small group with one analyst pays. Adjust for time before you use them.

2008 $38,000 Baseline Yearly license, 1 concurrent user
2009 $47,140 Up 24.1% Renewal of Genedata Screener software
2010 $48,550 Up 3.0% Software license

A different product, the same vendor habits

Genedata Analyst at the NIH, ten renewals in a row

Analyst is Genedata's software for omics and other high dimensional biological data, not for screening plates, and it is priced separately. It belongs on this page for one reason: eleven NIAID awards show exactly how Genedata renews a license, and that is the behavior a Screener buyer will meet too.

2017 $22,500
2018 $22,500
2019 $22,500
2020 $23,600
2021 $23,600
2022 $24,700
2023 $25,900 rate
2024 $25,900
2025 $25,900
2026 $25,900

Flat years are normal

$22,500 for three straight years, $23,600 twice, then $25,900 for four. Most renewals did not move at all.

Steps of about 5 percent

When the price moved, it moved 4.9, 4.7 and 4.9 percent. That is a policy figure you can name at renewal.

Short terms are prorated

The 11 month 2023 term cost $23,742, which is exactly eleven twelfths of $25,900. The annual rate rose that year even though the invoice fell.

The whole record

Every federal award to Genedata, oldest first

Twenty one awards written to Genedata (USA), Inc., read from USAspending.gov, about $1.05m for Screener and $263,000 for Analyst. The product column follows each award's own wording and its buyer. No reseller award for Genedata appears in the record.

Term	Buyer	Product	How the award describes it	Amount
Jun 2008 to Jun 2009	EPA	Screener	Genedata Screener yearly license (1 concurrent user)	$38,000
May 2009 to Jun 2010	EPA	Screener	Renewal of Genedata Screener software	$47,140
Jun 2010 to Jun 2011	EPA	Screener	Software license	$48,550
Jan 2013 to Jul 2014	Army	Screener	Screener Assay Analyzer	$140,000
Aug 2015 to Sep 2017	NIH, NIAID	Analyst	Genedata Analyst version 9.0	$22,000
Sep 2015 to Jul 2016	Army	Screener	Genedata license	$3,000
Sep 2016 to Sep 2018	Army	Screener	Subscription GDUSS0851FD	$147,400
Jan 2017 to Jan 2018	NIH, NIAID	Analyst	Genedata Analyst version 9.0	$22,500
Jan 2018 to Jan 2019	NIH, NIAID	Analyst	Software license for Genedata Analyst	$22,500
Sep 2018 to Sep 2019	Army, USAMRIID	Screener	GDSUSS0851FD	$77,000
Jan 2019 to Jan 2020	NIH, NIAID	Analyst	Genedata software renewal	$22,500
Sep 2019	Army	Screener	Software license, maintenance and support of Genedata Screener	$85,340
Jan 2020 to Jan 2021	NIH, NIAID	Analyst	Genedata Analyst software license	$23,600
Sep 2020 to Sep 2023	Defense Health Agency	Screener	Genedata software license	$330,240
Feb 2021 to Jan 2022	NIH, NIAID	Analyst	Analyst license and support renewal	$23,600
Feb 2022 to Jan 2023	NIH, NIAID	Analyst	Software license and support for Genedata Analyst	$24,700
Mar 2023 to Jan 2024	NIH, NIAID	Analyst	Renewal of license, maintenance and support, 11 months	$23,742
Feb 2024 to Jan 2025	NIH, NIAID	Analyst	Renewal of license, maintenance and support	$25,900
Sep 2024 to Sep 2026	Defense Health Agency	Screener	Genedata Screener software base year	$133,175
Mar 2025 to Jan 2026	NIH, NIAID	Analyst	Renewal of license, maintenance and support	$25,900
Sep 2026 to Sep 2027	HHS for NIH, NIAID	Analyst	Genedata Analyst bioinformatics software program	$25,900

The figure left out of the timeline

A $3,000 Army award in 2015 is described only as a Genedata license. It is far too small to be a Screener year and probably covers an add-on or a short extension, so it is shown in the table and kept out of every rate on this page.

What moves your number

Four things that decide a Screener quote

Concurrent users

The only award that states a seat count is the EPA's first one, a yearly license for one concurrent user at $38,000 in 2008. Screener is licensed by simultaneous users rather than named people, so the number to negotiate is how many analysts work in it at the same time, not how many have an account.

Which assay modules

Genedata describes Screener as covering biochemical, cellular, high content, biophysical, kinetic, ion channel and mass spec assays, plus large molecule formats. A quote is built from the modules your assays need. The 2013 Army award names an Assay Analyzer, which is one of those building blocks, priced at $140,000 for its first 18 months.

Subscription term

The Army moved from a two year subscription to one year awards, then to a three year license. The three year award is the one where the annual figure jumped, so a longer term on its own did not buy a lower rate. Ask for the annual price written into every year of a multi year term.

Hosting and validation

Genedata offers cloud access and secure on premise deployment, and supports GxP work. A validated, regulated deployment costs more to deliver than a research install, and that work shows up in the quote whether or not it has its own line.

Where this tool fits, and where it does not

Screener reads the plates you ran. We help decide what goes on them.

Before the plate

Rank the library

A pre-trained antibacterial model returns a predicted MIC band per organism across a 6 strain ESKAPE panel, with the mechanism class and the closest published analogs, so the compounds least likely to work never take a well. Lab works out to about $0.60 a screen.

On the plate

Run the assay

Broth microdilution, growth inhibition or a reporter assay. Nothing replaces the measurement, and no prediction should be reported as one.

After the plate

Analyze it in Screener

Normalization, curve fitting, quality control, hit calling and a standard record across sites. For a team running many campaigns, Screener does this better than anything we sell, and the license earns its keep.

The two are not substitutes. The question is order and size: a library ranked first is a smaller campaign, and a smaller campaign needs fewer concurrent analysts. For the triage step itself, the compound library screening software page shows how a ranked SDF comes back, and the antibacterial screening API drops the same predictions into the pipeline that feeds your plates.

Who reads this page

Six reasons people look this number up

You are pricing a screening data platform

Start from a signed annual figure, $73,700 to $110,080 on Army terms, instead of a sales call.

You are facing a Screener renewal

Set the increase against the Army series, which stepped 4.5, then 10.8, then 29 percent.

You run a small HTS campaign

One concurrent user cost $38,000 a year in 2008. Check that your plate count justifies a platform.

You are comparing data analysis vendors

Put Screener beside ActivityBase, Dotmatics or an in house pipeline on the same seat count.

You screen against bacteria

Screener scores the plates you ran. It does not choose which compounds were worth running.

Your library is bigger than your plate budget

Ranking the library by predicted activity first shrinks the campaign Screener has to analyze.

Screener is one line in a discovery budget. The drug discovery software cost pillar puts every suite we have priced side by side, the Pipeline Pilot pricing record covers the workflow tool many screening groups wire around it, and toxicology teams triaging the same hits can check the Derek Nexus pricing record.

Questions people ask before buying

Genedata pricing, answered plainly

How much does Genedata Screener cost?

Genedata publishes no price. Public US federal awards show what government labs paid. The Army held a Screener subscription at $73,700 a year in 2016 and 2017, $77,000 in 2018, $85,340 in 2019 and about $110,080 a year from 2020 to 2023. The EPA paid $38,000 in 2008 for one concurrent user. Commercial quotes come off a separate sheet.

Is Genedata Screener a subscription?

Yes, on the public record. The Army bought it as a subscription under one product code in 2016 and 2018, and later as an annual license with maintenance and support. Every Army award ends on September 14 or 15, which marks them as one continuing agreement renewed each year rather than separate purchases.

How much does a Genedata Screener license cost per user?

The only award that states a seat count is from the EPA in 2008: a yearly license for one concurrent user at $38,000. The EPA renewed at $47,140 in 2009 and $48,550 in 2010, a 3.0 percent step. Concurrent means simultaneous users, so one license can serve several analysts who do not work in it at the same time.

Who owns Genedata?

Danaher. Genedata announced on August 19, 2024 that it was joining Danaher Corporation, and it sits in Danaher's Life Sciences segment. Genedata had been an independent company based in Basel, Switzerland. The federal awards on this page are written to Genedata (USA), Inc., the US entity that signs American contracts.

How often does Genedata raise its prices?

Not every year. Genedata Analyst at the NIH held at $22,500 for three years, then rose about 4.9 percent twice, and has sat at $25,900 since 2023. The Screener subscription rose 4.5 percent in 2018 and 10.8 percent in 2019, then about 29 percent on the 2020 three year license, which likely included added scope.

What is the difference between Genedata Screener and Genedata Analyst?

Screener analyzes screening assays: plate based HTS and HCS data, dose response curves, quality control and hit calling. Analyst analyzes omics and other high dimensional biological data. They are separate products with separate licenses, which is why the NIH Analyst renewals at $22,500 to $25,900 a year cost a fraction of the Army Screener subscription.

What are the alternatives to Genedata Screener?

Screening data platforms that labs commonly compare include IDBS ActivityBase, Dotmatics, CDD Vault and in house pipelines built on open source curve fitting. None publishes a full commercial price either. Compare them on the same concurrent user count and the same assay types, because Screener is priced by both.

Does Genedata Screener predict antibacterial activity?

No. Screener analyzes results from assays you have already run: normalizing plates, fitting curves, flagging quality problems and calling hits. It does not predict whether an untested compound will inhibit a bacterial strain. That read-out comes from running the assay or from a pre-trained activity model before the plate is built.

Pricing

Published, monthly, and on this page

Full plan comparison

Lab is $149 a month for 250 screens with batches up to 50 compounds, which is $1,788 across a year. Discovery is $499 for 2,000 screens, batches up to 1,000, and adds the API. Program is $1,490 for 10,000 screens with batches up to 10,000. One year of the Army Screener subscription at $110,080 would pay for about 62 years of Lab, or 6.2 years of Program. That comparison is only fair for the triage step, which is the one we do.

Save 50 percent with yearly billing, charged once a year.

Lab

$74 /mo

$888 charged once a year

250 screens a month against the standard panels, with CSV export.

Get started

Academic AMR lab, 1 to 2 chemists

Discovery

Put fewer, better compounds on the next plate

Paste a compound you already know the MIC for, read the panel, then upload the library you were about to screen.

Run a screen first

What you are agreeing to

Your compounds stay yours
Never used for model training
Deletable on request
No card needed to create your account